DCA Unearths Spurious Medicine Racket In Vijayawada

Vijaywada : The Department of Drugs Control Administration of the State government has busted a spurious drug racket in Vijayawada.

The Drugs Inspector has established that certain drugs manufactured by reputed pharma companies are imitated, and manufactured in a manner that would deceive unsuspecting consumers. The department further learnt that the unauthorised dealers are supplying substandard medicines by falsely labelling them as products manufactured by a reputed pharma company.

These counterfeit and spurious drugs would cause severe and fatal damage to one’s health as they are not manufactured by the original drug companies. The materials used in the drugs and the conditions being maintained at the manufacturing facility are of dubious quality, and it is likely that the ingredients can be toxic and can even cause death, said B. Anvesh Reddy, Drugs Inspector, Vijayawada Zone-IV of the Drug Control Administration in his complaint lodged with the Bhavanipuram police in Vijayawada on September 6 (Wednesday). The Hindu has accessed the complaint of the Drugs Inspector, a copy of the First Information Report (FIR) and other laboratory findings related to the drug racket.

The FIR has been registered against P.D.M.K.R.G. Krishna Murthy, of Lakshmi Padmavathi Pharma at Vasavi Pharma Market Complex in Vijayawada, and N. Kiran Kumar of Vidyadharapuram in Vijayawada under Sections 420 (cheating and dishonestly inducing delivery of property), 471 (using as genuine a forged document), 274 (adulteration of drugs) and 275 (selling adulterated drugs) of the Indian Penal Code (IPC).

Related Posts

  • Pharma
  • May 8, 2025
  • 111 views
CEO speaks: India’s AI-Powered Pharma Revolution: The Next Big Wave in Healthcare

A digital revolution is sweeping through the pharmaceutical industry, and it’s powered by artificial intelligence (AI). From automating drug discovery to making clinical trials more efficient and driving breakthroughs in…

Suven Pharmaceuticals renamed as Cohance Lifesciences

Suven Pharmaceuticals announced that the Ministry of Corporate Affairs, Government of India (MCA), has approved change of name of the Company from Suven Pharmaceuticals to Cohance Lifesciences, with effect from…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

CEO speaks: India’s AI-Powered Pharma Revolution: The Next Big Wave in Healthcare

CEO speaks: India’s AI-Powered Pharma Revolution: The Next Big Wave in Healthcare

Suven Pharmaceuticals renamed as Cohance Lifesciences

Suven Pharmaceuticals renamed as Cohance Lifesciences

Dabur misses estimates, profit drops 8% to Rs 320 crore

Dabur misses estimates, profit drops 8% to Rs 320 crore

Russian govt to take additional measures to avoid drug shortages

Russian govt to take additional measures to avoid drug shortages